5/9/2025

Expansion of ISO/IEC 17025:2017 accreditation provides third-party validation of biomedical, pharmaceutical, and consumer product test methods Exponent has expanded the scope of its...

Source: Finnhub

5/9/2025

Although many equity markets slipped in January, they recovered over the next two months for a strong first quarter of 2024.

Source: SeekingAlpha

5/8/2025

2025 Investor Presentation © 2025 Exponent, Inc. | Privileged & Confidential 1 ...

Source: Finnhub

5/4/2025

Key Insights Exponent's estimated fair value is US$79.29 based on 2 Stage Free Cash Flow to Equity Exponent's US$76.78...

Source: Yahoo

5/2/2025

Despite flat revenues and decreased net income, Exponent Inc (EXPO) leverages its diversified portfolio and strategic hiring to position for long-term growth.

Source: Yahoo

5/1/2025

Scientific consulting firm Exponent (NASDAQ:EXPO) announced better-than-expected revenue in Q1 CY2025, with sales up 6% year on year to $145.5 million. On the other hand, next quarter’s revenue guidance of $130 million was less impressive, coming in 3.8% below analysts’ estimates. Its GAAP profit of $0.52 per share was 8% above analysts’ consensus estimates.

Source: Yahoo

5/1/2025

MENLO PARK, Calif. AP) — Exponent Inc. EXPO) on Thursday reported earnings of $26.7 million in its first quarter.

Source: Yahoo

5/1/2025

MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on June 20, 2025 to all common stockholders of record as of June 6, 2025. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and paymen

Source: Yahoo

5/1/2025

MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. “Exponent’s first quarter results exceeded expectations, reinforcing both the resilience of our diversified business model and the value we deliver,” said Dr. Catherine Corrigan, President and Chief Executive Officer. “Our failure analysis expertise drove increased dispute-related activities in the chemicals, transporta

Source: Yahoo

5/1/2025

Exponent, Inc. (NASDAQ:EXPO) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ETCompany ParticipantsJoni Konstantelos - MD, Riveron Consulting,...

Source: SeekingAlpha

5/1/2025

MENLO PARK, Calif., May 01, 2025 -- Exponent, Inc. today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. Exponent's first quarter results...

Source: Finnhub

5/1/2025

MENLO PARK, Calif., May 01, 2025 -- Exponent, Inc. today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on June 20, 2025...

Source: Finnhub

4/30/2025

Scientific consulting firm Exponent (NASDAQ:EXPO) will be announcing earnings results tomorrow afternoon. Here’s what to expect.

Source: Yahoo

4/28/2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Source: Yahoo

4/26/2025

We recently published a list of the 10 Overlooked Dividend Stocks to Buy Now. In this article, we are going to take a look at where Exponent, Inc. (NASDAQ:EXPO) stands against other overlooked dividend stocks. In recent times, dividend investing—also known as equity income—has fallen out of favor. Once a widely followed and dependable strategy, […]

Source: Yahoo

4/24/2025

Approximately 76 million people in the U.S. live with obesity. In addition to changes in diet and exercise, treatment for this chronic disease often includes antiobesity medications . ...

Source: Finnhub

4/22/2025

The court's decision vacates FDA's 2024 rule over LDTs, pointing to oversight authority by Clinical Laboratory Improvement Amendments On March 31, the U.S. District Court for the...

Source: Finnhub

4/16/2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at business process outsourcing & consulting stocks, starting with Exponent (NASDAQ:EXPO).

Source: Yahoo

4/10/2025

MENLO PARK, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2025 financial results for the period ended April 4, 2025 following the close of the market on Thursday, May 1, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to disc

Source: Yahoo

4/10/2025

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?

Source: Yahoo